EUVIMEDSkopri EUVIMED
Open access · CC BY 4.0

Targeting hexokinase 2 to induce breast cancer cell senescence

Helmut Bischof, Katarina Cisarova, Sandra Burgstaller, Mia Schwerer, Markus Absenger-Novak, Philipp J Jost, Roland Malli, Wolfgang F Graier, Robert Lukowski

British Journal of Pharmacology · 2025

DOI: 10.1111/bph.70282 ↗

At a glance

Journal article in British Journal of Pharmacology, 2025. Written by Helmut Bischof and 8 co-authors. Institution: Gottfried Schatz Research Center, Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria. Major MEDLINE topics: Hexokinase, Cellular Senescence, Breast Neoplasms, Pyruvates. Cited 2 times so far (Crossref); 39 references. The full text is freely available (open access, CC BY 4.0). Funded by: Austrian Science Fund, Deutsche Forschungsgemeinschaft, Interfaculty Centre for Pharmacogenomics and Pharma Research.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Background and Purpose Hexokinase 2 (HK2) is a key enzyme linked to high tumour cell proliferation. Its inhibitors such as 3‐bromopyruvic acid (3‐BP) induce cancer cell death, highlighting HK2 modulation as potential anti‐cancer treatment. However, standard chemotherapies often cause the emergence of senescent cancer cells, which goes along with cell metabolic reprogramming and treatment failure. This study explores whether targeting HK2 can induce cancer cell senescence and whether metabolic changes in senescent cancer cells are tied to the cellular HK2 status. Experimental Approach The expression of hexokinase 1 (HK1) and HK2 was assessed using immunoblot and immunofluorescence analysis in cell lines and in primary murine breast cancer (BC) cells. The senescence‐inducing potential of HK2 inhibition and the effect of chemotherapy‐induced senescence on HK1 and HK2 expression were assessed. Cell‐based approaches were complemented by analysing single‐cell RNA sequencing data from BC patients. Key Results BC cell sensitivity to HK2 inhibition did not correlate with HK2 expression levels. Consistently, senescence was linked to a decrease in HK2 and an increase in HK1 expression. Moreover, genetic knockdown of HK2 induced senescence, indicating that a change in the HK2/HK1 ratio drives, rather than results, from cellular senescence. This shift in HK2/HK1 ratio was confirmed in single‐cell RNA sequencing data of BC biopsies. Conclusions and Implications Expressional shifts in the HK2/HK1 ratio may serve as a novel marker for BC cell senescence. Whereas targeting HK2 shows promise in untreated cancers, senescence‐inducing anti‐cancer therapies may limit the effectiveness of HK2‐targeted treatments in pre‐treated cancer patients.

Subjects

MeSH terms (MEDLINE)

HexokinaseCellular SenescenceBreast NeoplasmsPyruvatesAntineoplastic AgentsHumansAnimalsFemaleMiceCell Line, Tumor

Author keywords

breast cancerhexokinase 1hexokinase 2metabolismsenescence

Substances

HexokinaseHK2 protein, humanPyruvatesbromopyruvateAntineoplastic Agents

Authors and institutions

  • Gottfried Schatz Research Center, Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria.
  • Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Department of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tuebingen, Tuebingen, Germany.
  • BioTechMed-Graz, Graz, Austria.
  • Center for Medical Research, CF Bioimaging, Medical University of Graz, Graz, Austria.

Funding

  • Austrian Science Fund
  • Deutsche Forschungsgemeinschaft
  • Interfaculty Centre for Pharmacogenomics and Pharma Research

Cite

APA

Bischof, H., Cisarova, K., Burgstaller, S., Schwerer, M., Absenger-Novak, M., Jost, P. J., Malli, R., Graier, W. F., & Lukowski, R. (2025). Targeting hexokinase 2 to induce breast cancer cell senescence. British Journal of Pharmacology. https://doi.org/10.1111/bph.70282

Vancouver

Bischof H, Cisarova K, Burgstaller S, Schwerer M, Absenger-Novak M, Jost PJ, et al. Targeting hexokinase 2 to induce breast cancer cell senescence. British Journal of Pharmacology. 2025. doi:10.1111/bph.70282

BibTeX
@article{Bischof2025,
  author = {Bischof, Helmut and Cisarova, Katarina and Burgstaller, Sandra and Schwerer, Mia and Absenger-Novak, Markus and Jost, Philipp J and Malli, Roland and Graier, Wolfgang F and Lukowski, Robert},
  title = {Targeting hexokinase 2 to induce breast cancer cell senescence},
  journal = {British Journal of Pharmacology},
  year = {2025},
  doi = {10.1111/bph.70282}
}
Start for free →